연구동향 분석

Original Article : The refit model for end-stage Liver disease-Na is not a better predictor of mortality than the refit model for end-stage Liver disease in patients with cirrhosis and ascites

( Jun Jae Kim ) ( Jeong Han Kim ) ( Ja Kyung Koo ) ( Yun Jung Choi ) ( Soon Young Ko ) ( Won Hyeok Choe ) ( So Young Kwon ) 2014년

논문상세정보
인용/피인용
' Original Article : The refit model for end-stage Liver disease-Na is not a better predictor of mortality than the refit model for end-stage Liver disease in patients with cirrhosis and ascites' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • ascites
  • endstageliverdisease
  • hyponatremia
  • liver cirrhosis
  • mortality
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8,157 0

0.0%

' Original Article : The refit model for end-stage Liver disease-Na is not a better predictor of mortality than the refit model for end-stage Liver disease in patients with cirrhosis and ascites' 의 참고문헌

  • Type and cause of liver disease in Korea: single-center experience, 2005-2010
    Sang Soo Lee Clinical and Molecular Hepatology 18 (3) : 309 ~ 315 [2012]
  • The new liver allocation system: Moving toward evidence-based transplantation policy
    Freeman RB Jr Liver Transpl 8 : 851 ~ 858 [2002]
  • Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites
    Serste T J Hepatol 57 : 274 ~ 280 - [2012]
  • Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list
    Myers RP PLoS One 8 : e51926 ~ - [2013]
  • Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
    Marcellin P Lancet 381 : 468 ~ 475 - [2013]
  • Predictive value of refit model for end-stage liver disease, refit model for endstage liver disease-Na, and pre-existing scoring system for 3-month mortality in Korean patients with cirrhosis
    Koo JK J Gastroenterol Hepatol 28 : 1209 ~ 1216 - [2013]
  • Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death
    Heuman DM Hepatology 40 : 802 ~ 810 - [2004]
  • Pathogenesis of water and sodium retention in cirrhosis
    Martin PY Kidney Int Suppl 59 : S43 ~ S49 [1997]
  • Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients
    Inoue M Kidney Int 32 : 198 ~ 203 - [1987]
  • Longterm entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
    Chang TT Hepatology 52 : 886 ~ 893 - [2010]
  • Evidence-based incorporation of serum sodium concentration into MELD
    Biggins SW Gastroenterology 130 : 1652 ~ 1660 - [2006]
  • Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
    Arroyo V Hepatology 23 : 164 ~ 176 - [1996]
  • Comparison of the model for end-stage liver disease (MELD), MELD-na and MELDNa for outcome prediction in patients with acute decompensated hepatitis
    Hsu CY Dig Liver Dis 42 : 137 ~ 142 - [2010]
  • Ascites improves upon [corrected] serum sodium plus [corrected]model for end-stage liver disease (MELD) for predicting mortality in patients with advanced liver disease
    Somsouk M Aliment Pharmacol Ther 30 : 741 ~ 748 - [2009]
  • A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation
    Leise MD Gastroenterology 140 : 1952 ~ 1960 - [2011]
  • A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
    Malinchoc M Hepatology 31 : 864 ~ 871 [2000]